THE ANAPHYLATOXINS C3A AND C5A ARE VASODILATORS IN THE CANINE CORONARY VASCULATURE INVITRO AND INVIVO

被引:53
|
作者
SCHUMACHER, WA
FANTONE, JC
KUNKEL, SE
WEBB, RC
LUCCHESI, BR
机构
[1] UNIV MICHIGAN,SCH MED,DEPT PHARMACOL,ANN ARBOR,MI 48109
[2] UNIV MICHIGAN,SCH MED,DEPT PATHOL,ANN ARBOR,MI 48109
[3] UNIV MICHIGAN,SCH MED,DEPT PHYSIOL,ANN ARBOR,MI 48109
来源
AGENTS AND ACTIONS | 1991年 / 34卷 / 3-4期
关键词
D O I
10.1007/BF01988727
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The effect of complement fragments on coronary blood flow in vivo and the contraction of coronary arteries in vitro was determined. In pentobarbital anesthetized dogs, intraarterial bolus injection of C3a and C5a, zymosan-activated serum and methylcholine in the coronary vascular bed caused transient and dose-dependent increases in coronary blood flow. Similar increases were obtained with 25-mu-g of C3a (104 +/- 13%, n = 5) and 0.1-mu-g of methylcholine (102 +/- 4%, n = 3). Smaller increases in blood flow were elicited by 25-mu-g of C5a (41 +/- 18%, n = 4) and 0.2 ml of zymosan-activated serum (48 +/- 5%, n = 4). None of these responses were associated with significant changes in left ventricular contractile force measured with a strain gauge, arterial blood pressure, and heart rate. C3a dilated the coronary vascular bed in conscious dogs with an activity equal to or greater than that observed in anesthetized dogs. Isolated canine coronary arteries that were precontracted with serotonin relaxed in response to C3a, whether or not the endothelium was intact. Overall these data suggest that physiologically high doses of anaphylactic complement fragments vasodilate the canine coronary circulation.
引用
收藏
页码:345 / 349
页数:5
相关论文
共 50 条
  • [1] C3a and C5a anaphylatoxins receptors
    Sayah, S
    Leon, P
    Chan, P
    Fontaine, M
    M S-MEDECINE SCIENCES, 1998, 14 (03): : 291 - 299
  • [2] CHEMOTACTIC RESPONSE TO HUMAN C3A AND C5A ANAPHYLATOXINS .1. EVALUATION OF C3A AND C5A LEUKOTAXIS INVITRO AND UNDER SIMULATED INVIVO CONDITIONS
    FERNANDEZ, HN
    HENSON, PM
    OTANI, A
    HUGLI, TE
    JOURNAL OF IMMUNOLOGY, 1978, 120 (01): : 109 - 115
  • [3] MICROVASCULAR EFFECTS OF ANAPHYLATOXINS C3A AND C5A
    BJORK, J
    HUGLI, TE
    SMEDEGARD, G
    JOURNAL OF IMMUNOLOGY, 1985, 134 (02): : 1115 - 1119
  • [4] INDUCTION OF LEUKOTRIENE FORMATION BY THE ANAPHYLATOXINS C3A AND C5A
    PISON, U
    KUNAU, WH
    DAMERAU, B
    KONIG, W
    IMMUNOBIOLOGY, 1983, 164 (3-4) : 265 - 265
  • [5] Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques
    Oksjoki, Riina
    Laine, Petri
    Helske, Satu
    Kreula, Pirjo Vehmaan
    Mayranpaa, Mikko I.
    Gasque, Philippe
    Kovanen, Petri T.
    Pentikainen, Markku O.
    ATHEROSCLEROSIS, 2007, 195 (01) : 90 - 99
  • [6] Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques
    Laine, P.
    Oksjoki, R.
    Helske, S.
    Vehmaan-Kreula, P.
    Mayranpaa, M. I.
    Gasque, P.
    Kovanen, P. T.
    Pentikainen, M. O.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 157 - 157
  • [7] ADSORPTION OF ANAPHYLATOXINS C3A AND C5A ON DIALYZERS POLYVINYLCHLORIDE BLOOD LINE - INVIVO STUDY
    KANDUS, A
    DRINOVEC, J
    PONIKVAR, R
    KLADNIK, S
    IVANOVICH, P
    KIDNEY INTERNATIONAL, 1989, 35 (01) : 250 - 250
  • [8] Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg
    Bajic, Goran
    Yatime, Laure
    Klos, Andreas
    Andersen, Gregers Rom
    PROTEIN SCIENCE, 2013, 22 (02) : 204 - 212
  • [9] ANAPHYLATOXINS C3A AND C5A ADSORPTION ON POLYACRYLONITRILE (PAN) MEMBRANE OF DIALYZER - INVIVO STUDY
    KANDUS, A
    DRINOVEC, J
    KLADNIK, S
    IVANOVICH, P
    KIDNEY INTERNATIONAL, 1988, 33 (01) : 226 - 226
  • [10] Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a
    Gutzmer, Ralf
    Koether, Brigitta
    Zwirner, Joerg
    Dijkstra, Dorothea
    Purwar, Rahul
    Wittmann, Miriam
    Werfel, Thomas
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (11) : 2422 - 2429